EP Wealth Advisors LLC Makes New $510,000 Investment in HealthEquity, Inc. $HQY

EP Wealth Advisors LLC acquired a new stake in shares of HealthEquity, Inc. (NASDAQ:HQY) during the second quarter, Holdings Channel.com reports. The firm acquired 5,649 shares of the company’s stock, valued at approximately $510,000.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. Ieq Capital LLC bought a new stake in shares of HealthEquity in the 2nd quarter worth about $2,848,000. Callan Family Office LLC purchased a new position in shares of HealthEquity during the 2nd quarter worth about $718,000. Keebeck Wealth Management bought a new position in HealthEquity during the 2nd quarter valued at about $457,000. Keating Financial Advisory Services Inc. bought a new position in HealthEquity during the 2nd quarter valued at about $234,000. Finally, Paralel Advisors LLC bought a new position in HealthEquity during the 2nd quarter valued at about $2,498,000. Hedge funds and other institutional investors own 99.55% of the company’s stock.

Insider Transactions at HealthEquity

In related news, EVP Delano Ladd sold 7,500 shares of the business’s stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $90.00, for a total value of $675,000.00. Following the completion of the sale, the executive vice president owned 91,141 shares in the company, valued at approximately $8,202,690. The trade was a 7.60% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gayle Furgurson Wellborn sold 2,439 shares of the stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $90.00, for a total value of $219,510.00. Following the completion of the transaction, the director directly owned 19,733 shares in the company, valued at approximately $1,775,970. This trade represents a 11.00% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 17,905 shares of company stock valued at $1,651,280. 1.60% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

Several analysts have issued reports on the stock. Royal Bank Of Canada raised their price objective on shares of HealthEquity from $100.00 to $108.00 and gave the stock an “outperform” rating in a research note on Wednesday, June 3rd. Barrington Research reaffirmed an “outperform” rating and set a $110.00 target price on shares of HealthEquity in a research note on Friday, May 22nd. Wall Street Zen raised HealthEquity from a “hold” rating to a “buy” rating in a research note on Saturday. Citizens Jmp increased their price target on HealthEquity from $110.00 to $111.00 and gave the stock a “market outperform” rating in a report on Monday, June 1st. Finally, Weiss Ratings raised HealthEquity from a “hold (c)” rating to a “hold (c+)” rating in a research note on Friday, June 5th. Eleven equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $110.93.

HealthEquity Stock Down 0.0%

Shares of HQY opened at $105.40 on Tuesday. The firm has a fifty day moving average price of $97.01 and a 200-day moving average price of $87.37. The company has a current ratio of 3.44, a quick ratio of 3.44 and a debt-to-equity ratio of 0.46. The firm has a market capitalization of $8.81 billion, a P/E ratio of 39.48, a P/E/G ratio of 1.77 and a beta of 0.21. HealthEquity, Inc. has a 12-month low of $72.76 and a 12-month high of $107.62.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings results on Thursday, May 28th. The company reported $1.24 EPS for the quarter, topping the consensus estimate of $1.11 by $0.13. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. The company had revenue of $354.64 million for the quarter, compared to the consensus estimate of $352.02 million. The business’s quarterly revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Equities research analysts expect that HealthEquity, Inc. will post 3.92 earnings per share for the current year.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.